JPS6345274A - Production of amide derivative of ai-77 compound and salt thereof - Google Patents
Production of amide derivative of ai-77 compound and salt thereofInfo
- Publication number
- JPS6345274A JPS6345274A JP10972387A JP10972387A JPS6345274A JP S6345274 A JPS6345274 A JP S6345274A JP 10972387 A JP10972387 A JP 10972387A JP 10972387 A JP10972387 A JP 10972387A JP S6345274 A JPS6345274 A JP S6345274A
- Authority
- JP
- Japan
- Prior art keywords
- lactone
- compound
- formula
- organic solvent
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 150000003839 salts Chemical class 0.000 title claims description 12
- 150000001408 amides Chemical class 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 title abstract description 12
- LOXFXXGTOVWWQV-YKRRISCLSA-N (3s,4s,5s)-3-amino-4,5-dihydroxy-6-[[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-6-oxohexanoic acid Chemical compound C1=CC(O)=C2C(=O)O[C@H]([C@@H](NC(=O)[C@@H](O)[C@@H](O)[C@@H](N)CC(O)=O)CC(C)C)CC2=C1 LOXFXXGTOVWWQV-YKRRISCLSA-N 0.000 claims abstract description 12
- LOXFXXGTOVWWQV-UHFFFAOYSA-N Amicoumacin B Natural products C1=CC(O)=C2C(=O)OC(C(NC(=O)C(O)C(O)C(N)CC(O)=O)CC(C)C)CC2=C1 LOXFXXGTOVWWQV-UHFFFAOYSA-N 0.000 claims abstract description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 150000002596 lactones Chemical class 0.000 claims abstract description 6
- 230000002378 acidificating effect Effects 0.000 claims abstract description 4
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 21
- 239000003960 organic solvent Substances 0.000 abstract description 9
- 241000194103 Bacillus pumilus Species 0.000 abstract description 5
- 239000002253 acid Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000000767 anti-ulcer Effects 0.000 abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000005915 ammonolysis reaction Methods 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 239000002689 soil Substances 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- -1 texturin Polymers 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920002157 Cellulin Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000635201 Pumilus Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、抗T:R傷活性を有する下記式(1)で示き
れるAI−77類のアミド誘導体およびその塩の製造法
に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for producing an amide derivative of the AI-77 type represented by the following formula (1) and a salt thereof having anti-T:R wounding activity.
(従来の技術)
本物質を製造する技術として発の法が知られている(特
公昭57−6913号)。すなわち、バチルス属に属す
る菌株全好気的条件で培養し、そC)培養r液から各種
のりaマドグラフィおよび有@溶媒抽出法などを組合せ
る繁雑な精製工程金経て製造されている。(Prior Art) As a technique for producing this substance, the Hatsuno method is known (Japanese Patent Publication No. 57-6913). That is, it is produced by culturing a bacterial strain belonging to the genus Bacillus under aerobic conditions, and then going through a complicated purification process that combines various glue atomography and solvent extraction methods from the culture solution.
(発明が解決しようとする問題点)
上記の従来法においてrよ1発酵生産量が200〜25
0 mcg/−と憔めて低く、fll製工程も複雑であ
る。したがって1本物質を高純度で工業的に大量に供給
でさる製造法の田現が望まれている。(Problem to be solved by the invention) In the above conventional method, the production amount of r 1 fermentation is 200 to 25
It is extremely low at 0 mcg/-, and the full production process is complicated. Therefore, there is a need for a production method that can industrially supply a single substance in large quantities with high purity.
(問題点yk解決するための手段)
本発明者らは、前記の便乗法に比し、医薬品として高純
度の尚該化合Wを工業的に大量に供給できる製造法定つ
いて鋭慧検討し友結果、当該化合物に比し、培養液中K
dるかに多量に発酊生産され、結晶性のため容易に培養
液から単離檀製が可能なAI−77−B i原料として
、簡単な化学合成法により、当該化付物を高純度に得る
方法を完成し次。(Means for solving the problem yk) Compared to the above-mentioned piggyback method, the present inventors have conducted an in-depth study on a manufacturing method that can industrially supply the compound W with high purity as a pharmaceutical in large quantities. , compared to the compound, K in the culture medium
AI-77-B is produced in much larger quantities during fermentation, and due to its crystallinity, it can be easily isolated from the culture solution. Complete the method to get the following.
すなわち、本発明は、AI−77−Bifi性条件下で
脱水災厄させて、下記式(II)
で示6れる5 A JJk :)クトン体とし、これに
アンモニアを反1δさせて、下記式(1)
で示芒れるA(−77類のアミド訪導体およびその塩を
製造する方法である。That is, in the present invention, a 6A JJk :) chthonic body represented by the following formula (II) is produced by dehydration under AI-77-Bifi conditions, and ammonia is added to the 6A JJk :) chthonic body to form the following formula ( 1) This is a method for producing A (-77 type amide visiting conductor and its salt) as shown in the following.
AI−77−Bは不発明者らによって虜次に土壌から分
離され、バチルス・プミルスに属する菌株と同定でれ之
AI−77休「工桑技術院第4066号」を培地に好気
的に培養することによシ、+の培養液中に蓄積されるか
ら、その培養液より採取することができる。AI-77-B was isolated from soil by the inventors and was identified as a strain belonging to Bacillus pumilus. By culturing, it accumulates in the positive culture solution and can be collected from the culture solution.
次に、上記したAI−77−Bの埋fヒ字的性状につい
て述べる。Next, the above-described characteristics of AI-77-B will be described.
AI−77−Hの質量分析値、紫外吸収値、赤外吸収1
直、N M R@を第1表に示し、溶解性は、水。Mass spectrometry value, ultraviolet absorption value, infrared absorption 1 of AI-77-H
Direct, NMR@ is shown in Table 1, and the solubility is in water.
メタノール、ジメチルホルムアミド、ジメチルスルホキ
シドに易溶で、その他の低級アルコール、ジオキサン、
テトラヒドロフランにや\難溶で、酢酸エチル、クロロ
ホルム、エーテル、ヘキサンおよびベンゼンに殆んど解
けない。安定性は、水浴液はアルカリに不安定で、室温
でも徐々にラクトンの氷解が進行する。Easily soluble in methanol, dimethylformamide, dimethyl sulfoxide, other lower alcohols, dioxane,
It is sparingly soluble in tetrahydrofuran, and almost insoluble in ethyl acetate, chloroform, ether, hexane, and benzene. Regarding stability, the water bath solution is unstable to alkalis, and the lactone de-ice gradually progresses even at room temperature.
培養にはバチルス属の一株の培養に関する一船釣知誠が
適用でれる。すなわち、窒素源、炭素源。For culturing, the method described by Ichifune Tsurichi, which concerns the cultivation of a strain of the genus Bacillus, can be applied. i.e. nitrogen source, carbon source.
無機塩、ビタミン、アミノ酸、核酸関連物質等。Inorganic salts, vitamins, amino acids, nucleic acid-related substances, etc.
該微生物の成育に必要な物質を含んだ培地に25〜40
Cで好気的に行なわれる。大規模に培t8ヲ行うには、
通気撹拌培養を行うのが有利である。25 to 40% in a medium containing substances necessary for the growth of the microorganism.
It is carried out aerobically at C. To carry out cultivation on a large scale,
It is advantageous to carry out an aerated agitation culture.
なお、AI−77株(工業技術院第4066号)の菌字
的件貞は下記のとおりである。The bacterial character of strain AI-77 (Agency of Industrial Science and Technology No. 4066) is as follows.
菌学的性質
a)各徨培地上における生育状態
■肉汁:培地にほとんど均一に混濁して皮膜はっくらな
い。Mycological properties a) Growth status on each culture medium ■ Juice: The medium is almost uniformly turbid and the film does not peel.
■肉汁寒天培地:コロニーの周辺はおおむねSmoot
h型を呈するが1時にはrough型を呈し。■Meat juice agar medium: The area around the colony is mostly smooth.
It exhibits h-type, but at 1 o'clock it becomes rough-type.
扁平に拡がる。色は不透明ないし半透明で、アイポリ−
色から白色を経てクリーム色となる。Spreads flat. The color is opaque or semi-transparent, with an eye-poly
The color changes from white to cream color.
色素はつくらない。No dyes are produced.
■グルコース肉汁寒天培地;肉汁寒天培地より生育は良
好、外観は肉汁寒天培地に同じ。■Glucose juice agar medium: Growth is better than meat juice agar medium, and the appearance is the same as meat juice agar medium.
■(ラチン培地;緩慢に液化する。■(Latin medium; liquefies slowly.
■ペプトン水;生育はや\抑制され、全体がや\混濁す
る。■Peptone water: Growth is slightly suppressed and the whole becomes slightly cloudy.
■リドマスミルク;ミルクta固しない。ペプトンfヒ
もしない。リドマスの変色も認められない。■ Lidmus milk; milk does not harden. I don't even use peptone. No discoloration of lid mass was observed.
■バレイショ培地;炎黄褐色に拡がって生育し。■Potato medium: Grows in a flame yellowish brown color.
細かな皺を生ずる。Causes fine wrinkles.
グルコース肉汁寒天培地における形態学的性状は0.5
〜Q、9 X 2.0〜5.0μの大きさの短稈状を呈
し、グラムifヒ性で楕円状ないし円筒状の胞子をつく
る。胞子はお\むね中央に位置し、ふくらみは明瞭でな
い。Morphological properties on glucose broth agar medium are 0.5
~Q,9 It exhibits a short culm shape with a size of 2.0 to 5.0μ, and produces elliptical to cylindrical spores that are gram-like. The spores are generally located in the center, and the bulge is not distinct.
b)生理的性質
■最適生育条件:pH5〜pH8,27〜35’C好気
性。b) Physiological properties ■Optimal growth conditions: pH 5 to pH 8, 27 to 35'C aerobic.
(!)生Hしうる条件; p H5,0〜10.0.1
0〜5C
1、〕)グラム染色性;dfヒ性がある。(!) Conditions that allow raw hydrogen; pH 5.0 to 10.0.1
0-5C 1, ]) Gram staining; df staining.
(り抗酸性;なし
くλ)メチルレッド試験;陽性
■フォーゲス・プコスカウエル反応;陽性■インドール
の生成ハ認められない。(Anti-acidity; no λ) Methyl red test: Positive ■Voges-Puchskauer reaction; Positive■No formation of indole was observed.
■億1ヒ水素の生成はほとんど認められない。■Hardly any generation of arsenic hydrogen is observed.
■アンモニアの生成は認められない。■No ammonia production was observed.
◎硝改塩の還元は認められない。◎Reduction of nitric salt is not allowed.
■カタラーゼの生成は旺盛である。■ Catalase production is vigorous.
■ゼラテンをゆるやかに液比する。■ Gently mix the gelaten with the liquid.
[相]澱粉を加水分解しない。[Phase] Does not hydrolyze starch.
[株]クエン酸ヲ利用する。[Co.] Use citric acid.
■7幅食塩培養液に生育する。■Grows in a 7-width salt culture solution.
に)メチレンブルーを還元しない。) Do not reduce methylene blue.
■尿素の利用性は微弱である。■Usability of urea is weak.
C)炭素源の利用性
フラクトース、サッカロース、グルコース、マンニット
を利用してat生成する。マンノース。C) Utilization of carbon sources At is produced using fructose, saccharose, glucose, and mannitol. Mannose.
トレハロースもわずかに利用して酸を生成する。A small amount of trehalose is also used to generate acid.
アラビノース、キシロース、ガラクトース、ラクトース
、マルトース、ラフィノース、ソルビット。Arabinose, xylose, galactose, lactose, maltose, raffinose, sorbitol.
イノジット、グリセロール、α−メチルグルコシノド、
イヌリン、テキストリン、デンプン、繊維素は利用しな
い。いずれの炭素源からもガスの発生は認められない。Inosit, glycerol, α-methylglucosinod,
Does not use inulin, texturin, starch, or cellulin. No gas generation was observed from either carbon source.
上記の諸性質1kBergey’s manual o
f DeterminativeBacteriolo
gy 7版および8版に照合すると1重囲はアラビノー
ス、キシロースがらmt生成しないし、牛乳のペプトン
rヒも載置も起こさない等の点で多少の相違点はあるが
、2\むねバチルス・プミルスの性質に一致して−る。The above properties 1kBergey's manual o
f Determinative Bacteriolo
When comparing the 7th and 8th editions of Gy, there are some differences, such as the single box does not produce mt from arabinose and xylose, and does not cause peptone reaction or placement in milk. It corresponds to the characteristics of Pumilus.
しtがって1重囲をバチルス・プミルスに属する一菌株
と判定し九が、同一の既知の1株が存在しないので、バ
チルス・プミルスAI−77と命名し九。本菌株は工業
技術院倣生物工業技vtI研究所に寄託委号第4066
号として寄託嘔れている。本発明において、このバチル
ス・プミルスAI−77株のすべての天然および人工変
異株のうち、AI−77FAの生産能を有する株ニすべ
て用いることができる。Therefore, we determined that the single circle was a strain belonging to Bacillus pumilus, but since there was no known identical strain, we named it Bacillus pumilus AI-77. This strain has been deposited with the Agency of Industrial Science and Technology VtI Research Institute, No. 4066.
It has been deposited as an issue. In the present invention, of all the natural and artificial mutant strains of Bacillus pumilus AI-77, all strains capable of producing AI-77FA can be used.
本発明の方法におけるAI−77−Bの培養による生産
と場養物からの採取工程は1%定の手段を利用すること
により実施される。すなわち、AI−77−B ij、
その生産m’に該醜が必要とする栄養源全含む培養液に
所定時間、好気的に培養することにより培養液中に蓄積
されるから、AI−77−Bの理化学的性[k利用して
、その培養液から櫨々の精製手段を組合せて採取される
。In the method of the present invention, the steps of producing AI-77-B by culturing and collecting it from a field culture are carried out using a 1% constant method. That is, AI-77-Bij,
The physicochemical properties of AI-77-B [k utilization Then, it is collected from the culture solution using a combination of purification methods.
発酵に用いられる栄養源としては、炭素源、窒素源、無
機塩類、その他必要に応じてビタミン類、アミノ酸類お
よび使用菌の生育に必要な諸栄養因子が使用される。炭
素源としては1例えば、グルコース、シュウクロース、
フラクトース、マンニトール、有機酸、糖蜜、fi粉類
、グリセリンなど。Nutrient sources used in fermentation include carbon sources, nitrogen sources, inorganic salts, and, if necessary, vitamins, amino acids, and various nutritional factors necessary for the growth of the bacteria used. Examples of carbon sources include glucose, sucrose,
Fructose, mannitol, organic acids, molasses, fi powder, glycerin, etc.
窒素源としては1例えば、コーン・スチープ・リカー、
大豆粉、ファマメディア、酵母エキス、肉エキス、ペプ
トンやカザミノ酸等の蛋白氷解物。Examples of nitrogen sources include corn steep liquor,
Soybean flour, Famamedia, yeast extract, meat extract, protein ice melt such as peptone and casamino acid.
アミノ酸、アンモニウム塩など、無機塩としては。Inorganic salts such as amino acids and ammonium salts.
例えば、ナトリウム、カリウム、カルシウム、マグネシ
ウム、鉄等の金属イオン、アンモニウム。For example, metal ions such as sodium, potassium, calcium, magnesium, iron, and ammonium.
リン酸、硫酸、塩素、カルボン酸等のイオンを含む塩が
使用される。生産菌の生育に必要な必須栄養賛素も培地
に含まれる必要があシ、ビタミン類。Salts containing ions such as phosphoric acid, sulfuric acid, chlorine, carboxylic acid, etc. are used. The culture medium must also contain essential nutrients and vitamins necessary for the growth of the producing bacteria.
アミノ酸類、核酸関連g!:素が必要に応じて添加され
る。Amino acids, nucleic acids related! : Elements are added as necessary.
AI−77−B生産園は樵々の条件で生育する。The AI-77-B production garden is grown under woodcutter conditions.
例えば、この微生物は広範囲の初期pH′t−有する種
々の培地に生育できる。しかし1発酵を開始する培地の
pHは6〜8.好ましくはpH6〜7で。For example, the microorganism can grow on a variety of media having a wide range of initial pH't-. However, the pH of the medium to start fermentation is 6-8. Preferably at pH 6-7.
一般に培地のpHは、微生物の生育にし九がって多少変
動する。培養温度は25〜40Cで好気的に60時間〜
96時間行われる。Generally, the pH of a culture medium changes somewhat depending on the growth of microorganisms. Culture temperature is 25-40C aerobically for 60 hours.
It will be held for 96 hours.
本発明のAI−77類生産菌は、寒天斜面上、振盪フラ
スコ中、中釜ないしは大型発酵タンク内で培養すること
ができる。大量生産ICは通気攪拌の発酵条件が好まし
い。通気攪拌の好気的な培養条件では、シリコン、ポリ
プロピレングリコール誘導体などの消泡剤を培地に加え
ることがAI−77−B成分の蓄積1kを増大させるの
に有効な場合もある。発酵の経過に関してAI−77−
Hの生産量は、培i!涙液の314mμにおける紫外部
吸収の増加によって追跡することができる。The AI-77-producing bacteria of the present invention can be cultured on an agar slant, in a shaking flask, in a medium pot or in a large fermentation tank. For mass-produced ICs, fermentation conditions of aeration and stirring are preferred. Under aerobic culture conditions with aeration and stirring, adding an antifoaming agent such as silicone or polypropylene glycol derivatives to the medium may be effective in increasing the accumulation 1k of the AI-77-B component. Regarding the progress of fermentation AI-77-
The production amount of H is culture i! It can be tracked by the increase in ultraviolet absorption at 314 mμ of the tear fluid.
好気的発酵条件下で生産し7tAI−77−Bは。7tAI-77-B produced under aerobic fermentation conditions.
主として発酵培地から各々の理化学的性質を利用して、
イオン交換樹脂、マクロ網状樹脂、ゲル濾過剤、吸着剤
等を使用したクロマトや溶媒抽出等を組合せて単離する
ことかできる。すなわち、好気的に48〜96時間培養
し友培養P液fzクロ網状樹脂1例えば、ローム・アン
ド・ハース社製アンバーライトXAD−2ま之はXAD
−4あるいは三菱化成製ダイアイオンHP−系に吸着さ
せ、水および有機溶媒あるいは両者の混合溶媒を用いて
浴出する。有機溶媒としては、特に水と親和性のあるC
1〜C4のアルコール類、アセトン、ジオキサン、テト
ラヒドロフラン等を使用することができる。例えば、メ
タノールを30係以上含有し友水により、AI−77−
33はマクロ網状樹脂XAD−2から脱離されるから、
この溶離液を減圧下に濃縮すると、AI−77−Hの粗
標品が得られる。マクロ網状樹脂VCよる精製を繰返す
ことにより、あるいは熱水またはメタノールから再結晶
δぜることにより、純度の高いAI−77−Hの結晶?
得ることができる。Mainly by utilizing the physical and chemical properties of each fermentation medium,
Isolation can be achieved by a combination of chromatography using ion exchange resins, macroreticular resins, gel filtration agents, adsorbents, solvent extraction, and the like. That is, after culturing aerobically for 48 to 96 hours, culture P liquid fz black reticular resin 1. For example, Amberlite XAD-2 manufactured by Rohm and Haas Co., Ltd.
-4 or Mitsubishi Kasei's Diaion HP- system, and bathed using water and an organic solvent or a mixed solvent of both. As an organic solvent, C, which has a particular affinity with water, is used.
1 to C4 alcohols, acetone, dioxane, tetrahydrofuran, etc. can be used. For example, AI-77-
Since 33 is desorbed from the macroreticular resin XAD-2,
This eluate is concentrated under reduced pressure to obtain a crude sample of AI-77-H. Highly pure crystals of AI-77-H can be obtained by repeated purification using macroreticular resin VC or by recrystallization from hot water or methanol.
Obtainable.
次に、AI−77−Bから下記式側 で示されるAI−77−B−r−ラクトンの製造は。Next, from AI-77-B, the following formula side The production of AI-77-Br-lactone is as follows.
よく乾燥し友AI−77−Bを乾燥した有機溶媒1例え
ば、アルコール類、テトラヒドロフラン等に溶解し、酸
を加えて酸性にすると、容易に脱水閉環してr−ラクト
ン体となる。溶媒を留去すると。When the organic solvent 1 obtained by thoroughly drying AI-77-B is dissolved in alcohols, tetrahydrofuran, etc. and made acidic by adding an acid, it easily undergoes dehydration and ring closure to form an r-lactone form. When the solvent is distilled off.
AI−77−B−r−ラクトンが一級アミンの塩として
得られる。遊離のアミンは、この塩?有機溶媒に溶解し
て希重曹水で洗浄し、有機溶媒を乾個することにより得
られる。AI-77-Br-lactone is obtained as a salt of a primary amine. Free amine is this salt? It is obtained by dissolving in an organic solvent, washing with diluted sodium bicarbonate solution, and drying the organic solvent.
上記式■の化合物から式(1)の化合物の製造は。The compound of formula (1) is produced from the compound of formula (1) above.
弐IのAI−77−B−γ−ラクトンを乾燥し次有機溶
媒に溶解し、乾燥アンモニアガスを吹き込むと。2. AI-77-B-γ-lactone was dried, then dissolved in an organic solvent, and dried ammonia gas was blown into it.
アンモノリシス反応によりr−ラクトンが開環して、弐
(1)の化合物が得られる。式(I)の化合物は。The r-lactone is ring-opened by the ammonolysis reaction to obtain compound 2 (1). The compound of formula (I) is.
これを有機溶媒にとかし、6量の酸を加えて溶媒を留去
し、アミンの塩にすると、より安定な化合物となる。医
薬として利用するには、安定なアミン塩として使用する
のが好ましい。When this is dissolved in an organic solvent, 6 amounts of acid are added and the solvent is distilled off to form an amine salt, a more stable compound is obtained. For use as a medicine, it is preferably used as a stable amine salt.
(発明の効果)
本発明により得られる式CI)の化合物は、第2表に示
す抗漬賜試験の結果から明らかなよう罠、優れた抗潰瘍
活性を有しており、また、抗菌活性も有している。(Effects of the Invention) The compound of formula CI) obtained according to the present invention has excellent anti-ulcer activity, as is clear from the results of the anti-corrosion test shown in Table 2, and also has antibacterial activity. have.
抗潰瘍性試Mは次のように実施した。Anti-ulcer test M was carried out as follows.
ラット(ウィスター、雄9体ム1502前後)を試験開
始の24時間前から絶食させた。生理食塩水を溶媒とし
て用い、試験fヒ合物の所定#度の溶液または@濁液を
調製して動物に経口的に投与し友。薬剤投与の1時間後
に金網篭にラット?固定し、21Cの水上中に胸部剣状
骨まで6時間浸漬し次。動物は類推脱臼して層殺し九後
、青?摘出して大湾に沿って切開し胃内壁ヲ剖見し之。Rats (Wistar, 9 males, approximately 1502 mm) were fasted for 24 hours before the start of the test. Using physiological saline as a solvent, a solution or suspension of the test compound at a predetermined concentration is prepared and administered orally to animals. Rats in a wire mesh cage 1 hour after drug administration? The specimen was fixed and immersed in 21C water up to the xiphoid bone for 6 hours. Animals are analogous and dislocated after layer killing nine, blue? It was removed, an incision was made along the large bay, and the inner wall of the stomach was dissected.
潰瘍の発生がほとんど認められないものを0とし。0 indicates that almost no ulcer is observed.
潰尋の発生程度によ#)0.5.1.2.3の採点全行
つ友。下記の式よシ潰嚇抑制率を算出し几。Depending on the degree of ulceration, the score is 0.5.1.2.3. Calculate the threat suppression rate using the formula below.
第2表に式(11の化合物の投与量とその潰瘍抑制率?
示す。Table 2 shows the formula (dosage of 11 compounds and their ulcer inhibition rate?
show.
第 2 表 (実施例) 以下に本発明の実施例を示す。Table 2 (Example) Examples of the present invention are shown below.
光分にt!i、燥し7tA!−77−810ミリモルを
水浴上で 10011I/のINHC6−エタノールに
溶解した。7’5’yちに減圧で溶媒を除去(パス@2
0〜50C)し、その後、真空ポンプを用いて残渣を光
分に乾燥し友。次に、この残渣に50−の0.5モルの
1炭酸ナトリウム溶液を加え、60〇−の酢酸エチルを
用い抽出を行なつ九。酢酸エチル層を飽和食塩水で洗つ
友後、芒硝を加え一晩放置し7几。T to the light minute! i, 7tA dried! -77-810 mmol was dissolved in 10011 I/INHC6-ethanol on a water bath. After 7'5'y, remove the solvent under reduced pressure (pass @2
0-50C) and then dry the residue using a vacuum pump. Next, 50-0.5 mol of 1-sodium carbonate solution was added to this residue, and extraction was performed using 600-mol of ethyl acetate.9. After washing the ethyl acetate layer with saturated saline, add Glauber's salt and leave it overnight for 7 liters.
芒硝kP別して酢はエチルを減圧で除去すると、3,9
89 (収准98%)のAI−77−B−r−ラクトン
が得られた。When ethyl is removed from vinegar under reduced pressure, 3,9
89 (yield 98%) of AI-77-Br-lactone was obtained.
上記AI−77−B−r−ラクトン5ミリモルを100
艷の無水メタノールにfg解し、水浴上で(10〜15
C)乾燥アンモニヤガスを50ミリモルまで吹きこみ、
2時間密栓して攪拌した後。100 mmol of the above AI-77-Br-lactone
Dissolve the fg in anhydrous methanol and boil on a water bath (10-15
C) Blowing dry ammonia gas up to 50 mmol,
After sealing and stirring for 2 hours.
溶媒を減圧で除去し、浅漬を50−のメタノールを加え
て溶解させ次。スーパーセル5?を加えて撹拌後、溶媒
を減圧で除去し、残渣ti線し友。The solvent was removed under reduced pressure, and the solution was dissolved by adding 50 methanol. Supercell 5? After stirring, the solvent was removed under reduced pressure, and the residue was subjected to a titanium ray.
この残渣を乳鉢を用い微細化し7を後、クロロホルムで
充填し几シリカゲルカラム(200j’)にのせた。最
初に500−のクロロホルムでカラムを洗った伎、
500 mlのクロロホルム:メタノール;3:1で生
Fy、w’を分離し次。分画51〜150ケ果め4縮に
固し、残渣に少量のメタノールを加え放置すると、1晶
沈澱が生じた。この沈澱を酢酸エチルで洗って集め、減
圧で溶媒を除去すると、0.519の目的18合物を得
た。This residue was pulverized using a mortar and then filled with chloroform and placed on a silica gel column (200j'). First, the column was washed with 500-ml chloroform.
Separate the raw Fy, w' with 500 ml of chloroform:methanol; 3:1. Fractions 51 to 150 were solidified to 4 concretions, and when a small amount of methanol was added to the residue and allowed to stand, a single crystal precipitate was formed. The precipitate was washed and collected with ethyl acetate, and the solvent was removed under reduced pressure to obtain 0.519 of the desired compound 18.
Claims (1)
クトン体とし、これにアンモニアを反応させることを特
徴とする下記式( I ) ▲数式、化学式、表等があります▼( I ) で示されるAI−77類のアミド誘導体およびその塩の
製造法。[Claims] The following formula (I) is characterized in that AI-77-B is dehydrated under acidic conditions to form a 5-membered ring lactone, and this is then reacted with ammonia. ▲ Numerical formulas, chemical formulas, tables, etc. ▼(I) A method for producing AI-77 amide derivatives and their salts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10972387A JPS6345274A (en) | 1987-05-07 | 1987-05-07 | Production of amide derivative of ai-77 compound and salt thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10972387A JPS6345274A (en) | 1987-05-07 | 1987-05-07 | Production of amide derivative of ai-77 compound and salt thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6168580A Division JPH0246585B2 (en) | 1979-07-11 | 1980-05-12 | AII77RUINOAMIDOJUDOTAITOSONOIYAKUTEKINIKYOYOSARERUEN |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6345274A true JPS6345274A (en) | 1988-02-26 |
JPH0371428B2 JPH0371428B2 (en) | 1991-11-13 |
Family
ID=14517591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10972387A Granted JPS6345274A (en) | 1987-05-07 | 1987-05-07 | Production of amide derivative of ai-77 compound and salt thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6345274A (en) |
-
1987
- 1987-05-07 JP JP10972387A patent/JPS6345274A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0371428B2 (en) | 1991-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3111470B2 (en) | Novel polypeptide compound and method for producing the same | |
JPH0764872B2 (en) | FR901228 substance and its manufacturing method | |
JPH0216756B2 (en) | ||
JPH02204499A (en) | Peptide derivative | |
SU1069631A3 (en) | Method for preparing tilactone and strain streptomyces fradiae nrrl 12188 for use in preparing tilactone | |
JP2833181B2 (en) | FR901375 substance and production method thereof | |
JPS6345274A (en) | Production of amide derivative of ai-77 compound and salt thereof | |
US3975235A (en) | Process for the production of cephamycin type antibiotic substances | |
JP3030896B2 (en) | WB968 substance group and production method thereof | |
US3264195A (en) | Process for the preparation of septacidin and derivatives | |
JPH01112988A (en) | Dc-107 and production thereof | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
FR2476128A1 (en) | MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF NARASIN AND CROPS CONTAINING THE PRODUCING MICROORGANISM STREPTOMYCES LYDICUS DEBOER AND AL- | |
JPH05271267A (en) | Fr901459 substance, and its production and use | |
JPS6334863B2 (en) | ||
JPS6351395A (en) | Antibiotic sf-2415 and production thereof | |
JPH02257887A (en) | New angucyclinon from streptmyces genus bacillus and preparation thereof | |
JPS5832960B2 (en) | Phosphodiestera - Zeosogaisuru | |
JP3386842B2 (en) | Novel ester of MJ202-72F3 substance | |
JPH04210679A (en) | Mer-a2026 a substance and b substance, production thereof and vasodilator comprising the same substance as active ingredient | |
WO1993024643A1 (en) | Farnesyltransferase inhibitors oh-4652 and production thereof | |
JPH0479892A (en) | Production of fr-901228 substance | |
JPH0725878A (en) | Platelet aggregation inhibitor pi-334 | |
JPS63162697A (en) | Novel antibiotic substance sf-2415a3 and sf-2415b3 and production thereof | |
JPH01252298A (en) | Novel compound wf 11605 and derivative thereof |